Bridgeway Capital Management’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
Other funds holding ETON
OM
EC
NCM
VCM
NPT
WIM
Bridgeway Capital Management's ETON Position: Q1 2026 in Review
Bridgeway Capital Management sold out of Eton Pharmaceutcials (ETON) in Q1 2026, closing a stake of 84,020 shares — an estimated $1.42M sold.
Bridgeway Capital Management first reported a position in ETON in Q1 2021 and held it in 20 quarters. The position peaked at $3.18M in Q4 2024. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.
- Bridgeway Capital Management reported no remaining Eton Pharmaceutcials position as of Q1 2026 after selling out during the quarter.
- Bridgeway Capital Management sold 84,020 Eton Pharmaceutcials shares in Q1 2026, an estimated $1.42M.
- Bridgeway Capital Management first reported a position in Eton Pharmaceutcials in Q1 2021 and held it in 20 quarters.
- Bridgeway Capital Management's Eton Pharmaceutcials position peaked at $3.18M in Q4 2024.
- 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.
Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.